remedx limited
remedx limited Company Information
Company Number
05044531
Website
www.remedx.co.ukRegistered Address
spring lodge 172 chester road, helsby, cheshire, WA6 0AR
Industry
Site preparation
Telephone
441179471007
Next Accounts Due
January 2025
Group Structure
View All
Shareholders
rsk environment limited 100%
remedx limited Estimated Valuation
The estimated valuation range for remedx limited, derived from financial data as of April 2023 and the most recent industry multiples, is between £607.7k to £1.6m
remedx limited Estimated Valuation
The estimated valuation range for remedx limited, derived from financial data as of April 2023 and the most recent industry multiples, is between £607.7k to £1.6m
remedx limited Estimated Valuation
The estimated valuation range for remedx limited, derived from financial data as of April 2023 and the most recent industry multiples, is between £607.7k to £1.6m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Remedx Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Remedx Limited Overview
Remedx Limited is a live company located in cheshire, WA6 0AR with a Companies House number of 05044531. It operates in the site preparation sector, SIC Code 43120. Founded in February 2004, it's largest shareholder is rsk environment limited with a 100% stake. Remedx Limited is a mature, mid sized company, Pomanda has estimated its turnover at £6.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Remedx Limited Health Check
Pomanda's financial health check has awarded Remedx Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of £6.8m, make it smaller than the average company (£12.8m)
£6.8m - Remedx Limited
£12.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (8%)
11% - Remedx Limited
8% - Industry AVG
Production
with a gross margin of 17.3%, this company has a comparable cost of product (21.3%)
17.3% - Remedx Limited
21.3% - Industry AVG
Profitability
an operating margin of 5% make it less profitable than the average company (7.1%)
5% - Remedx Limited
7.1% - Industry AVG
Employees
with 15 employees, this is below the industry average (35)
15 - Remedx Limited
35 - Industry AVG
Pay Structure
on an average salary of £46.2k, the company has an equivalent pay structure (£46.2k)
- Remedx Limited
£46.2k - Industry AVG
Efficiency
resulting in sales per employee of £456.5k, this is more efficient (£247.1k)
£456.5k - Remedx Limited
£247.1k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (47 days)
5 days - Remedx Limited
47 days - Industry AVG
Creditor Days
its suppliers are paid after 22 days, this is quicker than average (44 days)
22 days - Remedx Limited
44 days - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (3 days)
0 days - Remedx Limited
3 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (19 weeks)
1 weeks - Remedx Limited
19 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 90.4%, this is a higher level of debt than the average (62.3%)
90.4% - Remedx Limited
62.3% - Industry AVG
remedx limited Credit Report and Business Information
Remedx Limited Competitor Analysis
Perform a competitor analysis for remedx limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
remedx limited Ownership
REMEDX LIMITED group structure
Remedx Limited has 1 subsidiary company.
Ultimate parent company
2 parents
REMEDX LIMITED
05044531
1 subsidiary
remedx limited directors
Remedx Limited currently has 7 directors. The longest serving directors include Mr Alasdair Ryder (Feb 2004) and Mr Peter Witherington (Feb 2004).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Alasdair Ryder | England | 62 years | Feb 2004 | - | Director |
| Mr Peter Witherington | 73 years | Feb 2004 | - | Director | |
| Mr Nigel Board | 61 years | Nov 2004 | - | Director | |
| Mr Simon Jackman | England | 53 years | Dec 2007 | - | Director |
| Mr Felipe Couto | 49 years | Feb 2010 | - | Director | |
| Ms Claire Knighton | 50 years | Aug 2011 | - | Director | |
| Mr Giacomo Maini | 55 years | Sep 2019 | - | Director |
REMEDX LIMITED financials
Remedx Limited's latest turnover from April 2023 is £6.8 million and the company has net assets of £294.9 thousand. According to their latest financial statements, Remedx Limited has 15 employees and maintains cash reserves of £103.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6,847,112 | 2,318,925 | 710,286 | 5,018,438 | 2,157,000 | 1,430,000 | 2,286,000 | 2,485,000 | 2,917,000 | 3,172,000 | 2,729,000 | 2,127,000 | 2,056,000 | |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Cost Of Sales | 5,665,542 | 1,490,053 | 196,788 | 1,903,788 | 1,179,000 | 599,000 | ||||||||
| Gross Profit | 1,181,570 | 828,872 | 513,498 | 3,114,650 | 978,000 | 831,000 | ||||||||
| Admin Expenses | 840,325 | 1,067,242 | 514,715 | 2,521,140 | 879,000 | 891,000 | ||||||||
| Operating Profit | 341,245 | -238,370 | -1,217 | 593,510 | 99,000 | -60,000 | -33,000 | -9,000 | -38,000 | 98,000 | 64,000 | 82,000 | -96,000 | |
| Interest Payable | 529 | 176 | 0 | 0 | 0 | 0 | 1,000 | 0 | 15,000 | 11,000 | 0 | 0 | 0 | |
| Interest Receivable | 0 | 0 | 0 | 3,252 | 5,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Pre-Tax Profit | 340,716 | -238,546 | -1,217 | 596,762 | 104,000 | -60,000 | -34,000 | -9,000 | -53,000 | 87,000 | 64,000 | 82,000 | -96,000 | |
| Tax | 4,128 | -23,868 | -24,529 | -138,966 | -14,000 | 0 | 0 | -3,000 | 8,000 | -20,000 | -16,000 | -35,000 | 8,000 | |
| Profit After Tax | 344,844 | -262,414 | -25,746 | 457,796 | 90,000 | -60,000 | -34,000 | -12,000 | -45,000 | 67,000 | 48,000 | 47,000 | -88,000 | |
| Dividends Paid | 0 | 0 | 0 | 0 | 30,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Retained Profit | 344,844 | -262,414 | -25,746 | 457,796 | 60,000 | -60,000 | -34,000 | -12,000 | -45,000 | 67,000 | 48,000 | 47,000 | -88,000 | |
| Employee Costs | 542,000 | 580,000 | 646,000 | 659,000 | 614,000 | 551,000 | 547,000 | |||||||
| Number Of Employees | 15 | 18 | 21 | 19 | 15 | 15 | 16 | 18 | 18 | 18 | 16 | 16 | ||
| EBITDA* | 375,219 | -193,583 | 77,030 | 625,506 | 139,000 | 1,000 | 52,000 | 90,000 | 74,000 | 174,000 | 122,000 | 187,000 | 42,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 179,512 | 185,684 | 83,793 | 145,460 | 125,000 | 115,000 | 160,000 | 198,000 | 240,000 | 326,000 | 295,000 | 161,000 | 161,000 | 233,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 179,512 | 185,684 | 83,793 | 145,460 | 125,000 | 115,000 | 160,000 | 198,000 | 240,000 | 326,000 | 295,000 | 161,000 | 161,000 | 233,000 |
| Stock & work in progress | 7,200 | 7,200 | 1,560 | 1,560 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 3,000 |
| Trade Debtors | 95,840 | 177,496 | 0 | 43,372 | 142,000 | 202,000 | 367,000 | 308,000 | 213,000 | 167,000 | 95,000 | 102,000 | 208,000 | 140,000 |
| Group Debtors | 945,001 | 4,485,771 | 3,571,172 | 1,131,591 | 499,000 | 219,000 | 220,000 | 200,000 | 230,000 | 225,000 | 111,000 | 86,000 | 132,000 | 101,000 |
| Misc Debtors | 1,753,538 | 571,401 | 418,840 | 1,073,542 | 883,000 | 134,000 | 74,000 | 184,000 | 205,000 | 260,000 | 219,000 | 707,000 | 129,000 | 254,000 |
| Cash | 103,183 | 8,278 | 56,131 | 104,765 | 5,000 | 50,000 | 443,000 | 129,000 | 50,000 | 372,000 | 606,000 | 497,000 | 305,000 | 200,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,904,762 | 5,250,146 | 4,047,703 | 2,354,830 | 1,531,000 | 607,000 | 1,106,000 | 823,000 | 700,000 | 1,026,000 | 1,033,000 | 1,394,000 | 776,000 | 698,000 |
| total assets | 3,084,274 | 5,435,830 | 4,131,496 | 2,500,290 | 1,656,000 | 722,000 | 1,266,000 | 1,021,000 | 940,000 | 1,352,000 | 1,328,000 | 1,555,000 | 937,000 | 931,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 349,329 | 396,932 | 90,763 | 52,866 | 334,000 | 91,000 | 236,000 | 428,000 | 112,000 | 363,000 | 296,000 | 527,000 | 190,000 | 264,000 |
| Group/Directors Accounts | 822,200 | 4,809,793 | 666,008 | 1,628,481 | 819,000 | 292,000 | 406,000 | 114,000 | 242,000 | 325,000 | 333,000 | 500,000 | 246,000 | 245,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 6,596 | 6,596 | 0 | 0 | 0 | 0 | 1,000 | 0 | 2,000 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,600,301 | 254,909 | 48,513 | 80,772 | 223,000 | 119,000 | 343,000 | 155,000 | 226,000 | 298,000 | 288,000 | 184,000 | 205,000 | 171,000 |
| total current liabilities | 2,778,426 | 5,468,230 | 805,284 | 1,762,119 | 1,376,000 | 502,000 | 986,000 | 700,000 | 582,000 | 986,000 | 917,000 | 1,211,000 | 641,000 | 680,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 10,993 | 17,589 | 0 | 0 | 0 | 0 | 0 | 0 | 4,000 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 2,613,787 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 10,993 | 17,589 | 2,613,787 | 0 | 0 | 0 | 0 | 1,000 | 4,000 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 2,789,419 | 5,485,819 | 3,419,071 | 1,762,119 | 1,376,000 | 502,000 | 986,000 | 701,000 | 586,000 | 986,000 | 917,000 | 1,211,000 | 641,000 | 680,000 |
| net assets | 294,855 | -49,989 | 712,425 | 738,171 | 280,000 | 220,000 | 280,000 | 320,000 | 354,000 | 366,000 | 411,000 | 344,000 | 296,000 | 251,000 |
| total shareholders funds | 294,855 | -49,989 | 712,425 | 738,171 | 280,000 | 220,000 | 280,000 | 320,000 | 354,000 | 366,000 | 411,000 | 344,000 | 296,000 | 251,000 |
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 341,245 | -238,370 | -1,217 | 593,510 | 99,000 | -60,000 | -33,000 | -9,000 | -38,000 | 98,000 | 64,000 | 82,000 | -96,000 | |
| Depreciation | 33,974 | 44,787 | 78,247 | 31,996 | 40,000 | 61,000 | 72,000 | 85,000 | 99,000 | 112,000 | 76,000 | 58,000 | 105,000 | 106,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32,000 |
| Tax | 4,128 | -23,868 | -24,529 | -138,966 | -14,000 | 0 | 0 | -3,000 | 8,000 | -20,000 | -16,000 | -35,000 | 8,000 | |
| Stock | 0 | 5,640 | 0 | -440 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,000 | 3,000 |
| Debtors | -2,440,289 | 1,244,656 | 1,741,507 | 724,505 | 969,000 | -106,000 | -31,000 | 44,000 | -4,000 | 227,000 | -470,000 | 426,000 | -26,000 | 495,000 |
| Creditors | -47,603 | 306,169 | 37,897 | -281,134 | 243,000 | -145,000 | -192,000 | 316,000 | -251,000 | 67,000 | -231,000 | 337,000 | -74,000 | 264,000 |
| Accruals and Deferred Income | 1,345,392 | 206,396 | -32,259 | -142,228 | 104,000 | -224,000 | 188,000 | -71,000 | -72,000 | 10,000 | 104,000 | -21,000 | 34,000 | 171,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 4,117,425 | -955,182 | -1,683,368 | -660,887 | -497,000 | -262,000 | 253,000 | -232,000 | -68,000 | 497,000 | -4,000 | 139,000 | -13,000 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -3,987,593 | 4,143,785 | -962,473 | 809,481 | 527,000 | -114,000 | 292,000 | -128,000 | -83,000 | -8,000 | -167,000 | 254,000 | 1,000 | 245,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | -1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -6,596 | 24,185 | 0 | 0 | 0 | -1,000 | 1,000 | -6,000 | 6,000 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | -2,613,787 | 2,613,787 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -529 | -176 | 0 | 3,252 | 5,000 | 0 | -1,000 | 0 | -15,000 | -11,000 | 0 | 0 | 0 | |
| cash flow from financing | -3,994,718 | 1,054,007 | 1,651,314 | 813,108 | 532,000 | -115,000 | -134,000 | -77,000 | -23,000 | -178,000 | 254,000 | -1,000 | 584,000 | |
| cash and cash equivalents | ||||||||||||||
| cash | 94,905 | -47,853 | -48,634 | 99,765 | -45,000 | -393,000 | 314,000 | 79,000 | -322,000 | -234,000 | 109,000 | 192,000 | 105,000 | 200,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -3,000 | 3,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 94,905 | -47,853 | -48,634 | 99,765 | -45,000 | -393,000 | 317,000 | 76,000 | -322,000 | -234,000 | 109,000 | 192,000 | 105,000 | 200,000 |
P&L
April 2023turnover
6.8m
+195%
operating profit
341.2k
-243%
gross margin
17.3%
-51.72%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2023net assets
294.9k
-6.9%
total assets
3.1m
-0.43%
cash
103.2k
+11.46%
net assets
Total assets minus all liabilities
Similar Companies
remedx limited company details
company number
05044531
Type
Private limited with Share Capital
industry
43120 - Site preparation
incorporation date
February 2004
age
20
accounts
Small Company
ultimate parent company
previous names
rsk remediation limited (September 2008)
rsk ensr remediation limited (January 2007)
incorporated
UK
address
spring lodge 172 chester road, helsby, cheshire, WA6 0AR
last accounts submitted
April 2023
remedx limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 12 charges/mortgages relating to remedx limited. Currently there are 1 open charges and 11 have been satisfied in the past.
remedx limited Companies House Filings - See Documents
| date | description | view/download |
|---|
